Clinical Trial Update: Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants [NA]

View source ↗

Summary

A clinical trial evaluating heterologous cord blood-derived red blood cells for transfusion in extremely preterm infants is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Neonatal Anemia
• Retinopathy of Prematurity

Drugs mentioned

• Cord blood-derived red blood cells (heterologous) (cord blood-derived red blood cells)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Extremely Premature Infant, Anemia Neonatal | NA | Status: NOT_YET_RECRUITING